Page last updated: 2024-11-04

terbutaline and Fatigue Syndrome, Chronic

terbutaline has been researched along with Fatigue Syndrome, Chronic in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kavelaars, A1
Kuis, W1
Knook, L1
Sinnema, G1
Heijnen, CJ1

Other Studies

1 other study available for terbutaline and Fatigue Syndrome, Chronic

ArticleYear
Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:2

    Topics: Adolescent; Adrenergic beta-Agonists; Blood Cells; Cells, Cultured; Child; Dexamethasone; Epinephrin

2000